Skip to main content
SpringerLink
Log in

Selection Guidelines for Upfront Surgical Intervention Versus Neoadjuvant Chemotherapy

  • Chapter
  • First Online:
Breast Cancer Essentials

  • 1141 Accesses

Abstract

Breast cancer management and treatment has been adapting to the new subclassification of breast cancer into different subtypes. In this chapter, we propose general guidelines to help treating surgeons in recommending upfront surgical intervention or referring the patient for neoadjuvant treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 84.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer. 1988;62(12):2507–16.

    Article  CAS  Google Scholar 

  2. Hortobagyi GN, Blumenschein GR, Spanos W, Montague ED, Buzdar AU, Yap HY, et al. Multimodal treatment of locoregionally advanced breast cancer. Cancer. 1983;51(5):763–8.

    Article  CAS  Google Scholar 

  3. Perloff M, Lesnick GJ. Chemotherapy before and after mastectomy in stage III breast cancer. Arch Surg. 1982;117(7):879–81.

    Article  CAS  Google Scholar 

  4. Schick P, Goodstein J, Moor J, Butler J, Senter KL. Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer. J Surg Oncol. 1983;22(4):278–82.

    Article  CAS  Google Scholar 

  5. Mieog JS, van der Hage JA, van de Velde CJ. Neoadjuvant chemotherapy for operable breast cancer. Br J Surg. 2007;94(10):1189–200.

    Article  CAS  Google Scholar 

  6. Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258–64.

    Article  Google Scholar 

  7. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455–61.

    Article  CAS  Google Scholar 

  8. Mamtani A, Barrio AV, King TA, Van Zee KJ, Plitas G, Pilewskie M, et al. How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study. Ann Surg Oncol. 2016;23(11):3467–74.

    Article  Google Scholar 

  9. Sakakibara M, Nagashima T, Kadowaki M, Onai Y, Fujimori T, Yokomizo J, et al. Clinical significance of axillary microresiduals after neoadjuvant chemotherapy in breast cancer patients with cytologically proven metastases. Ann Surg Oncol. 2009;16(9):2470–8.

    Article  Google Scholar 

  10. Quantum Leap Healthcare Collaborative. I-SPY 2 trial of neoadjuvant treatment for locally advanced breast cancer. https://www.ispytrials.org/i-spy-platform/i-spy2. Accessed 30 Jan 2019.

  11. Yang VQ, Han G, Mougalian SS, Killelea BK, Horowitz N, Chagpar AB, et al. Predictors of complete pathological response to neoadjuvant chemotherapy for breast cancer: 19,310 cases from the national cancer database treated in 2010 and 2011 (Abstract No. P3-11-02). Cancer Res. 2015;75(9 Supplement).

    Google Scholar 

  12. Kim JY, Park HS, Kim S, Ryu J, Park S, Kim SI. Prognostic nomogram for prediction of axillary pathologic complete response after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer. Medicine (Baltimore). 2015;94(43):e1720.

    Article  CAS  Google Scholar 

  13. Petruolo OA, Pilewskie M, Patil S, Barrio AV, Stempel M, Wen HY, et al. Standard pathologic features can be used to identify a subset of estrogen receptor-positive, HER2 negative patients likely to benefit from neoadjuvant chemotherapy. Ann Surg Oncol. 2017;24(9):2556–62.

    Article  Google Scholar 

  14. Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609–18.

    Article  Google Scholar 

Download references

Disclosures

No conflicts of interest to disclose.

Author information

Authors and Affiliations

  1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Mahmoud El-Tamer

  2. Weill Medical College at Cornell University, New York, NY, USA

    Mahmoud El-Tamer

Authors
  1. Mahmoud El-Tamer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahmoud El-Tamer .

Editor information

Editors and Affiliations

  1. European Academia of Senology, Düsseldorf, Germany

    Mahdi Rezai

  2. Dokuz Eylül University, Izmir, Turkey

    Mehmet Ali Kocdor

  3. University of Kocaeli, Ä°zmit/Kocaeli, Turkey

    Nuh Zafer Canturk

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

El-Tamer, M. (2021). Selection Guidelines for Upfront Surgical Intervention Versus Neoadjuvant Chemotherapy. In: Rezai, M., Kocdor, M.A., Canturk, N.Z. (eds) Breast Cancer Essentials. Springer, Cham. https://doi.org/10.1007/978-3-030-73147-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-73147-2_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-73146-5

  • Online ISBN: 978-3-030-73147-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation